Latest filings (excl ownership)
S-3ASR
Automatic shelf registration
19 Apr 24
PRE 14A
Preliminary proxy
19 Apr 24
10-K
2023 FY
Annual report
27 Feb 24
8-K
Zai Lab Announces Full-Year 2023
27 Feb 24
8-K
Entry into a Material Definitive Agreement
8 Feb 24
10-K/A
2022 FY
Annual report (amended)
22 Dec 23
10-Q
2023 Q3
Quarterly report
7 Nov 23
8-K
Zai Lab Announces Third Quarter 2023
7 Nov 23
10-Q
2023 Q2
Quarterly report
7 Aug 23
8-K
Zai Lab Announces Second Quarter 2023
7 Aug 23
F-6EF
Automatic registration for ADRs (foreign)
14 Jul 23
8-K
Zai Lab Announces Promotion of Yajing Chen to Chief Financial Officer
6 Jul 23
8-K
Zai Lab and argenx Announce Approval of VYVGART® (efgartigimod alfa injection) for Generalized Myasthenia Gravis in China
30 Jun 23
8-K
Submission of Matters to a Vote of Security Holders
20 Jun 23
8-K
Other Events
6 Jun 23
10-Q
2023 Q1
Quarterly report
9 May 23
8-K
Zai Lab Announces First Quarter 2023
9 May 23
ARS
2022 FY
Annual report to shareholders
1 May 23
DEF 14A
Definitive proxy
28 Apr 23
PRE 14A
Preliminary proxy
18 Apr 23
8-K
Other Events
31 Mar 23
10-K
2022 FY
Annual report
1 Mar 23
8-K
Zai Lab Announces Full-Year 2022 Financial Results and Recent Corporate Updates
1 Mar 23
8-K
Zai Lab Appoints Michel Vounatsos
9 Jan 23
8-K
Zai Lab and Novocure Announce Pivotal LUNAR Study in Non-Small Cell Lung Cancer Met Primary Overall Survival Endpoint
5 Jan 23
10-Q
2022 Q3
Quarterly report
9 Nov 22
8-K
Zai Lab Announces Third Quarter 2022
9 Nov 22
8-K
Departure of Directors or Certain Officers
28 Oct 22
S-8
Registration of securities for employees
28 Oct 22
8-K
Entry into a Material Definitive Agreement
27 Sep 22
10-Q
2022 Q2
Quarterly report
9 Aug 22
8-K
Zai Lab Announces Second Quarter 2022
9 Aug 22
8-K
Departure of Directors or Certain Officers
3 Aug 22
8-K
Departure of Directors or Certain Officers
22 Jun 22
UPLOAD
Letter from SEC
10 Jun 22
UPLOAD
Letter from SEC
10 Jun 22
8-K/A
Changes in Registrant's Certifying Accountant
1 Jun 22
8-K
Other Events
31 May 22
DEFA14A
Additional proxy soliciting materials
20 May 22
10-Q
2022 Q1
Quarterly report
10 May 22
Latest ownership filings
4
Joshua L Smiley
5 Apr 24
4
Harald Reinhart
5 Apr 24
4
Frazor Titus Edmondson III
5 Apr 24
4
Ying Du
5 Apr 24
4
Yajing Chen
5 Apr 24
4
Rafael Amado
5 Apr 24
144
Notice of proposed sale of securities
4 Apr 24
144
Notice of proposed sale of securities
4 Apr 24
144
Notice of proposed sale of securities
4 Apr 24
144
Notice of proposed sale of securities
4 Apr 24
144
Notice of proposed sale of securities
4 Apr 24
4
Frazor Titus Edmondson III
3 Apr 24
4
Harald Reinhart
3 Apr 24
4
Ying Du
3 Apr 24
4
Yajing Chen
3 Apr 24
4
Rafael Amado
3 Apr 24
4
Joshua L Smiley
3 Apr 24
144
Notice of proposed sale of securities
2 Apr 24
144
Notice of proposed sale of securities
2 Apr 24
144
Notice of proposed sale of securities
2 Apr 24
144
Notice of proposed sale of securities
2 Apr 24
4
Rafael Amado
19 Mar 24
4
Frazor Titus Edmondson III
19 Mar 24
4
Ying Du
15 Mar 24
144
Notice of proposed sale of securities
15 Mar 24
144
Notice of proposed sale of securities
15 Mar 24
4
Joshua L Smiley
4 Mar 24
SC 13G
Capital World Investors
12 Feb 24
SC 13G/A
FMR LLC
9 Feb 24
SC 13G
WELLINGTON MANAGEMENT GROUP LLP
8 Feb 24
SC 13G/A
Invesco Ltd.
1 Feb 24
4
Rafael Amado
3 Jan 24
4
Ying Du
3 Jan 24
4
Harald Reinhart
3 Jan 24
4
Frazor Titus Edmondson III
3 Jan 24
144
Notice of proposed sale of securities
3 Jan 24
144
Notice of proposed sale of securities
3 Jan 24
144
Notice of proposed sale of securities
3 Jan 24
144
Notice of proposed sale of securities
2 Jan 24
4
Joshua L Smiley
18 Dec 23